Startup
NT
Neusignal Therapeutics
Funding rounds in 2026
Amounts are the full announced figure. Grey amounts aren't counted in equity totals. † includes debt, grants or other non-equity (hover for detail).
| Date | Company | Stage | Amount | Investors | Sector |
|---|---|---|---|---|---|
| 3 Jul 2026 | NTNeusignal Therapeutics | Series B | ¥5.32B | Keio Innovation InitiativeNippon Venture CapitalAngel Bridge +4 | Healthcare |